Paul A. Decker

19.3k citations

255 papers · 9.7k indexed · 1 hit paper · h-index 54

Impact in

Genetics top 0.5%
- Glioma Diagnosis and Treatment
Pulmonary and Respiratory Medicine top 0.2%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Pleural and Pulmonary Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research

Papers in

Genetics 48
- Glioma Diagnosis and Treatment 45
Physiology 72
- Smoking Behavior and Cessation 54

Co-authors: Jay H. Ryu Hassan F. Nadrous Karla V. Ballman Darrell R. Schroeder Jann N. Sarkaria Joe B. Putnam Christi A. Patten Brett L. Carlson
Journals: CHEST Journal (17 papers)Neuro-Oncology (15 papers)Mayo Clinic Proceedings (12 papers)Nicotine & Tobacco Research (11 papers)Journal of Clinical Oncology (10 papers)
Partner nations: United States Canada Belarus

In The Last Decade

Paul A. Decker

245 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial 2011 · 492 citations

Peers

Countries citing papers authored by Paul A. Decker

Since Specialization

Citations

This map shows the geographic impact of Paul A. Decker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Decker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Decker more than expected).

Fields of papers citing papers by Paul A. Decker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Decker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Decker. The network helps show where Paul A. Decker may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul A. Decker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul A. Decker Line = papers co-authored together Paul A. Decker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adapting a Financial Incentives Intervention for Smoking Cessation With Alaska Native Families: Phase 1 Qualitative Research to Inform the Aniqsaaq (To Breathe) Study Nicotine & Tobacco Research ·Pamela S. Sinicrope, Terrence Lyons and Hilary Matfess, Daniele Rispoli, Kathryn R. Koller, Diane K. King, S. Bingham, Татьяна Владимировна Лисовая, Judith J. Prochaska, Bijan J. Borah, Paul A. Decker, Michael G. McDonell, S. Jeffers, Timothy K. Thomas, Christi A. Patten	2024	0
2	Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization Science Translational Medicine ·松本伯夫, Daniel J. Laverty, Surabhi Talele, 伸一宮森, Brett L. Carlson, M.N. Zapotochnaya, Katrina K. Bakken, Danielle M. Burgenske, Paul A. Decker, Rachael A. Vaubel, Jeanette E. Eckel‐Passow, Rohit Bhargava, Zhenkun Lou, Petra Hamerlik, Brendan A.C. Harley, William F. Elmquist, Zachary D. Nagel, Shiv K. Gupta, Jann N. Sarkaria	2024	14
3	NIMG-57. PERFORMANCE OF DEEP LEARNING IN MGMT PROMOTER METHYLATION STATUS PREDICTION USING BRAIN MRI: RESULTS FROM A LARGE COHORT OF IDH-WILDTYPE GLIOMAS TESTED BY A SINGLE METHYLATION ASSAY Neuro-Oncology ·Gian Marco Conte, Mana Moassefi, Shahriar Faghani, Francesco Sanvito, Paul A. Decker, Sani H. Kizilbash, Jeanette E. Eckel‐Passow, Ahmed K. Metawee, Bradley J. Erickson	2023	1
4	Aniqsaaq (To Breathe): Study protocol to develop and evaluate an Alaska Native family-based financial incentive intervention for smoking cessation Contemporary Clinical Trials Communications ·Christi A. Patten, Kathryn R. Koller, Diane K. King, Judith J. Prochaska, Pamela S. Sinicrope, Deepanwita Dutta, Paul A. Decker, S. Bingham, João Guilherme Grassi dos Anjos, Daniele Rispoli, Byung Ho Noh, Kate Burgess, Bijan J. Borah, Timothy K. Thomas	2023	4
5	Rethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease Journal of Allergy and Clinical Immunology Global ·Thanai Pongdee, Sheila M. Manemann, Paul A. Decker, Nicholas B. Larson, Sungrim Moon, Jill M. Killian, Hongfang Liu, Hirohito Kita, Suzette J. Bielinski	2022	16
6	Facebook Intervention to Connect Alaska Native People With Resources and Support to Quit Smoking: CAN Quit Pilot Randomized Controlled Trial Nicotine & Tobacco Research ·Christi A. Patten, Kathryn R. Koller, Pamela S. Sinicrope, Judith J. Prochaska, Colleen Young, Ken Resnicow, Paul A. Decker, Christine A. Hughes, Deepashree, 重徳船吉, Ming Huang, Timothy K. Thomas	2022	5
7	White blood cells and chronic rhinosinusitis: a Mendelian randomization study Allergy Asthma and Clinical Immunology ·Thanai Pongdee, Suzette J. Bielinski, Paul A. Decker, Hirohito Kita, Nicholas B. Larson	2022	5
8	Inherited genetics of adult diffuse glioma and polygenic risk scores—a review Neuro-Oncology Practice ·Jeanette E. Eckel‐Passow, Daniel H. Lachance, Paul A. Decker, Thomas M. Kollmeyer, Matthew Kosel, Kim Jong Whi, Susan L. Slager, Margaret Wrensch, W. Oliver Tobin, Robert B. Jenkins	2022	3
9	In Vivo Efficacy of Tesevatinib in EGFR -Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling Molecular Cancer Therapeutics ·Sani H. Kizilbash, Shiv K. Gupta, Karen E. Parrish, Janice K. Laramy, Minjee Kim, Gautham Gampa, Brett L. Carlson, Katrina K. Bakken, Ann C. Mladek, Mark A. Schroeder, Paul A. Decker, William F. Elmquist, Jann N. Sarkaria	2021	10
10	PLEKHA7, an Apical Adherens Junction Protein, Suppresses Inflammatory Breast Cancer in the Context of High E-Cadherin and p120-Catenin Expression International Journal of Molecular Sciences ·Cui Ya-r, Antonis Kourtidis, Ryan W. Feathers, Zheng Jie-yi, 寿夫古池, Paul A. Decker, Aziza Nassar, Idris Tolgay Ocal, Sejal Shah, Panos Z. Anastasiadis	2021	4
11	Social Media Intervention to Promote Smoking Treatment Utilization and Cessation Among Alaska Native People Who Smoke: Protocol for the Connecting Alaska Native People to Quit Smoking (CAN Quit) Pilot Study SHILAP Revista de lepidopterología ·Pamela S. Sinicrope, Kathryn R. Koller, Judith J. Prochaska, Christine A. Hughes, J. Zhang, Paul A. Decker, Christie A. Flanagan, Deepashree, Khajornkiat Srinuansom, Wilma Dubois, Ken Resnicow, Timothy K. Thomas, Christi A. Patten	2019	13
12	Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy European Radiology ·Matthew Koslow, Jason R. Young, Eunhee S. Yi, Misbah Baqir, Paul A. Decker, Geoffrey B. Johnson, Jay H. Ryu	2018	27
13	Restricted Delivery of Talazoparib Across the Blood–Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma Molecular Cancer Therapeutics ·Sani H. Kizilbash, Shiv K. Gupta, Kenneth Tou En Chang, Carol A. Mancuso Nichols, Karen E. Parrish, Brett L. Carlson, Katrina K. Bakken, Ann C. Mladek, Mark A. Schroeder, Paul A. Decker, Gaspar J. Kitange, Yuqiao Shen, Ying Feng, Andrew A. Protter, William F. Elmquist, Jann N. Sarkaria	2017	60
14	CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma Clinical Cancer Research ·Tony Avril, Amandine Etcheverry, Raphaël Pineau, Joanna Obacz, Gwénaële Jégou, Florence Jouan, Pierre‐Jean Le Reste, Masumeh Hatami, Rivka R. Colen, Brett L. Carlson, Paul A. Decker, Jann N. Sarkaria, Élodie Vauléon, F. Ducastelle, Anne Clavreul, Jean Mosser, Éric Chevet, Véronique Quillien	2017	34
15	Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas Clinical Cancer Research ·Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen D. McPhail, Yan W. Asmann, Jan B. Egan, Jackline de Paula Ayres-Silva, David Schiff, M. Beatriz S. Lopes, Paul A. Decker, Riccardo Valdez, Raoul Tibes, Bruce W. Eckloff, Thomas E. Witzig, A. Keith Stewart, Rafaël Fonseca, Brian Patrick O’Neill	2015	150
16	The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma Clinical Cancer Research ·Jenny L. Pokorny, David Calligaris, Shiv K. Gupta, 高汝熹, Kyle J. Sloan, Katrina K. Bakken, Brett L. Carlson, Mark A. Schroeder, Debra L. Evans, Zhenkun Lou, Paul A. Decker, Jeanette E. Eckel‐Passow, Vincenzo Pucci, Bennett Ma, Stuart D. Shumway, William F. Elmquist, Nathalie Y.R. Agar, Jann N. Sarkaria	2015	71
17	Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts Clinical Cancer Research ·Gaspar J. Kitange, Ann C. Mladek, Brett L. Carlson, Mark A. Schroeder, Jenny L. Pokorny, Ling Cen, Paul A. Decker, Wenting Wu, Gwen Lomberk, Shiv K. Gupta, Raúl Urrutia, Jann N. Sarkaria	2012	125
18	Occult Metastases in Lymph Nodes Predict Survival in Resectable Non–Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial Journal of Clinical Oncology ·Valerie W. Rusch, Debra Hawes, Paul A. Decker, Sue Ellen Martin, Andrea Abati, Rodney J. Landreneau, G. Alexander Patterson, Richard Inculet, David R. Jones, Richard Malthaner, Robbin G. Cohen, Karla V. Ballman, Joe B. Putnam, Richard J. Côté	2011	80
19	Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage European Respiratory Journal ·Fabien Maldonado, Joseph G. Parambil, Eunhee S. Yi, Paul A. Decker, Jay H. Ryu	2009	41
20	Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course Journal of Clinical Oncology ·Zakia Lagha Ameur, Brian Patrick O’Neill, Mark E. Law, Paul A. Decker, David M. Kurtz, Caterina Giannini, Alyx B. Porter, Paul J. Kurtin, Patrick B. Johnston, Ahmet Doǧan, Ellen D. Remstein	2008	78

About Paul A. Decker

Paul A. Decker is a scholar working on Genetics, Physiology, Applied Psychology, Pulmonary and Respiratory Medicine and Oncology, having authored 255 papers that have together received 9.7k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (54 papers), Glioma Diagnosis and Treatment (45 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (27 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (16 papers), Behavioral Health and Interventions (13 papers), Brain Metastases and Treatment (11 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Genetics (1.5k citations), Pulmonary and Respiratory Medicine (4.2k citations), Physiology (2.0k citations), Applied Psychology (347 citations) and Oncology (1.4k citations). Paul A. Decker has collaborated with scholars based in United States, Canada and Belarus. Frequent co-authors include Jay H. Ryu, Hassan F. Nadrous, Karla V. Ballman, Darrell R. Schroeder, Jann N. Sarkaria, Joe B. Putnam, Christi A. Patten, Brett L. Carlson, Robert Vassallo and Mark A. Schroeder. Their work appears in journals such as CHEST Journal, Neuro-Oncology, Mayo Clinic Proceedings, Nicotine & Tobacco Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact